Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs
02:48pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Iovance (IOVA) is progressing well with the clinical development of its pipeline candidates. It expects to file a BLA with the FDA, seeking approval for its lead candidate to treat metastatic melanoma
Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs
12:20pm, Wednesday, 22'nd Jun 2022
Iovance (IOVA) is progressing well with the clinical development of its pipeline candidates. It expects to file a BLA with the FDA, seeking approval for its lead candidate to treat metastatic melanoma
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
09:15pm, Friday, 17'th Jun 2022 GlobeNewswire Inc.
SAN CARLOS, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today ann
Iovance Biotherapeutics Appoints Wendy L. Dixon, Ph.D., to Board of Directors
08:01pm, Monday, 13'th Jun 2022 GlobeNewswire Inc.
SAN CARLOS, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor inf
Iovance Biotherapeutics to Present at Upcoming Conferences
04:01pm, Wednesday, 08'th Jun 2022
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today annou
Why Iovance Stock Leaped 17% Higher Today
10:52pm, Friday, 03'rd Jun 2022 The Motley Fool
Several insiders have been purchasing the company's common shares lately.
Why Iovance Stock Leaped 17% Higher Today
06:52pm, Friday, 03'rd Jun 2022
Several insiders have been purchasing the company's common shares lately.
Insiders Buy Around $10M Of 3 Stocks
11:53am, Friday, 03'rd Jun 2022 Benzinga
Although the Dow Jones jumped more than 400 points on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
12:54pm, Sunday, 29'th May 2022 MarketWatch
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Iovance (IOVA) Down After Announcing Data From Melanoma Study
06:43pm, Friday, 27'th May 2022 Zacks Investment Research
Results from a cohort of the phase II study evaluating Iovance's (IOVA) melanoma candidate were not as superior as data from another cohort of the same study.
Why Iovance Biotherapeutics Was Halved Today
05:08pm, Friday, 27'th May 2022 The Motley Fool
Investors are seeing the proverbial glass as half-empty rather than half-full.
Iovance (IOVA) Down After Announcing Data From Melanoma Study
03:49pm, Friday, 27'th May 2022
Results from a cohort of the phase II study evaluating Iovance's (IOVA) melanoma candidate were not as superior as data from another cohort of the same study.
Why Iovance Biotherapeutics Was Halved Today
01:08pm, Friday, 27'th May 2022
Investors are seeing the proverbial glass as half-empty rather than half-full.
Even this pessimistic Bank of America strategist says the bear-rally bandwagon has room to charge ahead
12:43pm, Friday, 27'th May 2022 MarketWatch
Michael Hartnett said there will be a point to fade the S&P 500 rally. But not yet.
Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?
10:41am, Friday, 27'th May 2022
Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment. The post Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?
